Human genetic variation is a determinant of nutrient efficacy and of tolerances and intolerances and has the potential to influence nutrient intake values (NIVs). Knowledge derived from the comprehensive identification of human genetic variation offers the potential to predict the physiological and pathological consequences of individual genetic differences and prevent and/or manage adverse outcomes through diet. Nutrients and genomes interact reciprocally; genomes confer differences in nutrient utilization, whereas nutrients effectively modify genome expression, stability, and viability. Understanding the interactions that occur among human genes, including all genetic variants thereof, and environmental exposures is enabling the development of genotype-specific nutritional regimens that prevent disease and promote wellness for individuals and populations throughout the life cycle. Genomic technologies may provide new criteria for establishing NIVs. The impact of a gene variant on NIVs will be dependent on its penetrance and prevalence within a population. Recent experiences indicate that few gene variants are anticipated to be sufficiently penetrant to affect average requirement (AR) values to a greater degree than environmental factors. If highly penetrant gene variants are identified that affect nutrient requirements, the prevalence of the variant in that country or region will determine the feasibility and necessity of deriving more than one AR or upper limit (UL) for affected genetic subgroups.
BaileyLB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677→T polymorphism affect cancer risk: Intake recommendations. J Nutr2003;133(11suppl 1):3748S–53S.
2.
BaileyLBGregoryJF3rd. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement. J Nutr1999;129:919–22.
3.
TishkoffSAWilliamsSM. Genetic analysis of African populations: Human evolution and complex disease. Nat Rev Genet2002;3:611–21.
4.
McCarthyJJHilfikerR. The use of single-nucleotide polymorphism maps in pharmacogenomics. Nat Biotechnol2000;18:505–8.
5.
WeinshilboumR. Inheritance and drug response. N Engl J Med2003;348:529–37.
6.
ClarkAGGlanowskiSNielsenRThomasPDKejariwalAToddMATanenbaumDMCivelloDLuFMurphyBFerrieraSWangGZhengXWhiteTJSninskyJJAdamsMDCargillM. Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios. Science2003;302:1960–3.
7.
VijgJSuhY. Genetics of longevity and aging. Annu Rev Med2005;56:193–212.
8.
KornmanKSMarthaPMDuffGW. Genetic variations and inflammation: A practical nutrigenomics opportunity. Nutrition2004;20:44–9.
9.
SchneemanBOMendelsonR. Dietary guidelines: Past experience and new approaches. J Am Diet Assoc2002;102:1498–500.
10.
SchneemanBO. Evolution of dietary guidelines. J Am Diet Assoc2003;103(12suppl 2):S5–9.
11.
EnattahNSSahiTSavilahtiETerwilligerJDPeltonenLJarvelaI. Identification of a variant associated with adult-type hypolactasia. Nat Genet2002;30:233–7.
12.
TishkoffSAVerrelliBC. Patterns of human genetic diversity: implications for human evolutionary history and disease. Annu Rev Genomics Hum Genet2003;4:293–340.
13.
GuttmacherAECollinsFS. Genomic medicine—A primer. N Engl J Med2002;347:1512–20.
14.
VenterJCAdamsMDMyersEW. The sequence of the human genome. Science2001;291:1304–51.
15.
TishkoffSAKiddKK. Implications of biogeography of human populations for ‘race’ and medicine. Nat Genet2004;36(11 suppl):S21–7.
16.
NachmanMWCrowellSL. Estimate of the mutation rate per nucleotide in humans. Genetics2000;156:297–304.
17.
WallJDPritchardJK. Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet2003;4:587–97.
18.
GabrielSBSchaffnerSFNguyenHMooreJMRoyJBlumenstielBHigginsJDeFeliceMLochnerAFaggartMLiu-CorderoSNRotimiCAdeyemoACooperRWardRLanderESDalyMJAltshulerD. The structure of haplotype blocks in the human genome. Science2002;296:2225–9.
19.
CrawfordDCNickersonDA. Definition and clinical importance of haplotypes. Annu Rev Med2005;56:303–20.
20.
Van BlerkomLM. Role of viruses in human evolution. Am J Phys Anthropol2003;suppl 37:14–46.
21.
BrookfieldJF. Mobile DNAs: The poacher turned gamekeeper. Curr Biol2003;13:R846–7.
22.
BatzerMADeiningerPL. Alu repeats and human genomic diversity. Nat Rev Genet2002;3:370–9.
23.
BamshadMWoodingSP. Signatures of natural selection in the human genome. Nat Rev Genet2003;4:99–111.
24.
WaterlandRAJirtleRL. Transposable elements: Targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol2003;23:5293–300.
25.
FrisoSChoiSW. Gene-nutrient interactions and DNA methylation. J Nutr2002;132(8 suppl):2382S–7S.
26.
FrisoSChoiSWDolnikowskiGGSelhubJ. A method to assess genomic DNA methylation using high-performance liquid chromatography/electrospray ionization mass spectrometry. Anal Chem2002;74:4526–31.
27.
WaterlandRAGarzaC. Potential mechanisms of metabolic imprinting that lead to chronic disease. Am J Clin Nutr1999;69:179–97.
28.
BlountBCMackMMWehrCMMacGregorJTHiattRAWangGWickramasingheSNEversonRBAmesBN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci USA1997;94:3290–5.
29.
FenechM. Micronutrients and genomic stability: A new paradigm for recommended dietary allowances (RDAs). Food Chem Toxicol2002;40:1113–7.
30.
FenechM. Genome health nutrigenomics: Nutrition and the science of optimal genome maintenance. Asia Pac J Clin Nutr2004;13(suppl):S15.
31.
FenechM. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today2002;7:1128–37.
32.
FenechM. Recommended dietary allowances (RDAs) for genomic stability. Mutat Res2001;480–481:51–4.
33.
MishraHNDasC. A review on biological control and metabolism of aflatoxin. Crit Rev Food Sci Nutr2003;43:245–64.
34.
AmesBN. DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res2001;475:7–20.
35.
GoswamiTRolfsAHedigerMA. Iron transport: Emerging roles in health and disease. Biochem Cell Biol2002;80:679–89.
36.
HedigerMARolfsAGoswamiT. Iron transport and hemochromatosis. J Investig Med2002;50:239S–46S.
37.
WolfeKHLiWH. Molecular evolution meets the genomics revolution. Nat Genet2003;33suppl:255–65.
38.
CooperDNKrawczakM. Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum Genet1989;83:181–8.
39.
KimuraM. Evolutionary rate at the molecular level. Nature1968;217:624–6.
AkeyJMZhangGZhangKJinLShriverMD. Interrogating a high-density SNP map for signatures of natural selection. Genome Res2002;12:1805–14.
42.
AkeyJMEberleMARiederMJCarlsonCSShriverMDNickersonDAKruglyakL. Population history and natural selection shape patterns of genetic variation in 132 genes. PLoS Biol2004;2:e286.
43.
WoodingS. Natural selection: Sign, sign, everywhere a sign. Curr Biol2004;14:R700–1.
44.
CollinsFS. What we do and don't know about ‘race’, ‘ethnicity’, genetics and health at the dawn of the genome era. Nat Genet2004;36(11 suppl):S13–5.
45.
ChakravartiA. To a future of genetic medicine. Nature2001;409:822–3.
46.
ReichDELanderES. On the allelic spectrum of human disease. Trends Genet2001;17:502–10.
47.
PritchardJK. Are rare variants responsible for susceptibility to complex diseases?Am J Hum Genet2001;69:124–37.
48.
PritchardJKCoxNJ. The allelic architecture of human disease genes: Common disease-common variant…or not?Hum Mol Genet2002;11:2417–23.
49.
JordeLBWatkinsWSBamshadMJ. Population genomics: A bridge from evolutionary history to genetic medicine. Hum Mol Genet2001;10:2199–207.
50.
JordeLBWatkinsWSBamshadMJDixonMERickerCESeielstadMTBatzerMA. The distribution of human genetic diversity: A comparison of mitochondrial, autosomal, and Y-chromosome data. Am J Hum Genet2000;66:979–88.
51.
JordeLBWoodingSP. Genetic variation, classification and ‘race’. Nat Genet2004;36(11 suppl):S28–33.
52.
BersaglieriTSabetiPCPattersonNVanderploegTSchaffnerSFDrakeJARhodesMReichDEHirschhornJN. Genetic signatures of strong recent positive selection at the lactase gene. Am J Hum Genet2004;74:1111–20.
53.
PoulterMHolloxEHarveyCBMulcareCPeuhkuriKKajanderKSarnerMKorpelaRSwallowDM. The causal element for the lactase persistence/non-persistence polymorphism is located in a 1 Mb region of linkage disequilibrium in Europeans. Ann Hum Genet2003;67(pt 4):298–311.
54.
WoodingS. PopHist: Inferring population history from the spectrum of allele frequencies. Bioinformatics2003;19:539–40.
55.
ToomajianCAjiokaRSJordeLBKushnerJPKreitmanM. A method for detecting recent selection in the human genome from allele age estimates. Genetics2003;165:287–97.
56.
ToomajianCKreitmanM. Sequence variation and haplotype structure at the human HFE locus. Genetics2002;161:1609–23.
57.
BeutlerE. Iron absorption in carriers of the C282Y hemochromatosis mutation. Am J Clin Nutr2004;80:799–800.
58.
BosronWFLiTK. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology1986;6:502–10.
59.
OsierMVPakstisAJSoodyallHComasDGoldmanDOdunsiAOkonofuaFParnasJSchulzLOBertranpetitJBonne-TamirBLuRBKiddJRKiddKK. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet2002;71:84–99.
60.
LoewMBoeingHSturmerTBrennerH. Relation among alcohol dehydrogenase 2 polymorphism, alcohol consumption, and levels of gamma-glutamyltransferase. Alcohol2003;29:131–5.
61.
OotaHPakstisAJBonne-TamirBGoldmanDGrigorenkoEKajunaSLKaromaNJKunguliloSLuRBOdunsiKOkonofuaFZhukovaOVKiddJRKiddKK. The evolution and population genetics of the ALDH2 locus: Random genetic drift, selection, and low levels of recombination. Ann Hum Genet2004;68(pt 2):93–109.
62.
NeelJV. Diabetes mellitus: A “thrifty” genotype rendered detrimental by “progress”?Am J Hum Genet1962;14:353–62.
63.
DiamondJ. The double puzzle of diabetes. Nature2003;423:599–602.
64.
RockmanMVWrayGA. Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol2002;19:1991–2004.
65.
VerrelliBCMcDonaldJHArgyropoulosGDestro-BisolGFromentADrousiotouALefrancGHelalANLoiseletJTishkoffSA. Evidence for balancing selection from nucleotide sequence analyses of human G6PD. Am J Hum Genet2002;71:1112–28.
66.
WatkinsWSRogersAROstlerCTWoodingSBamshadMJBrassingtonAMCarrollMLNguyenSVWalkerJAPrasadBVReddyPGDasPKBatzerMAJordeLB. Genetic variation among world populations: Inferences from 100 Alu insertion polymorphisms. Genome Res2003;13:1607–18.
67.
TishkoffSAVarkonyiRCahinhinanNAbbesSArgyropoulosGDestro-BisolGDrousiotouADangerfieldBLefrancGLoiseletJPiroAStonekingMTagarelliATagarelliGToumaEHWilliamsSMClarkAG. Haplotype diversity and linkage disequilibrium at human G6PD: Recent origin of alleles that confer malarial resistance. Science2001;293:455–62.
68.
BaierLJPermanaPAYangXPratleyREHansonRLShenGQMottDKnowlerWCCoxNJHorikawaYOdaNBellGIBogardusC. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest2000;106:R69–73.
69.
InoueINakajimaTWilliamsCSQuackenbushJPuryearRPowersMChengTLudwigEHSharmaAMHataAJeunemaitreXLalouelJM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest1997;99:1786–97.
70.
WrayGAHahnMWAbouheifEBalhoffJPPizerMRockmanMVRomanoLA. The evolution of transcriptional regulation in eukaryotes. Mol Biol Evol2003;20:1377–419.
71.
WrightAFCarothersADPirastuM. Population choice in mapping genes for complex diseases. Nat Genet1999;23:397–404.
72.
WoodingSKimUKBamshadMJLarsenJJordeLBDraynaD. Natural selection and molecular evolution in PTC, a bitter-taste receptor gene. Am J Hum Genet2004;74:637–46.
73.
AmesBNElson-SchwabISilverEA. High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased K(m)): Relevance to genetic disease and polymorphisms. Am J Clin Nutr2002;75:616–58.
74.
YoungVR. 2001 W.O. Atwater Memorial Lecture and the 2001 ASNS President's Lecture: Human nutrient requirements: The challenge of the post-genome era. J Nutr2002;132:621–9.
StoverPJ. Physiology of folate and vitamin B12 in health and disease. Nutr Rev2004;62(6 pt 2):S3–12; discussion S13.
79.
BrodyLCConleyMCoxCKirkePNMcKeeverMPMillsJLMolloyAMO'LearyVBParle-McDermottAScottJMSwansonDA. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: Report of the Birth Defects Research Group. Am J Hum Genet2002;71:1207–15.
80.
MaJStampferMJGiovannucciEArtigasCHunterDJFuchsCWillettWCSelhubJHennekensCHRozenR. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res1997;57:1098–102.
81.
GuentherBDSheppardCATranPRozenRMatthewsRGLudwigML. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol1999;6:359–65.
82.
EspositoGVitaglianoLSantamariaRViolaAZagariASalvatoreF. Structural and functional analysis of aldolase B mutants related to hereditary fructose intolerance. FEBS Lett2002;531:152–6.
83.
FullertonSMClarkAGWeissKMNickersonDATaylorSLStengardJHSalomaaVVartiainenEPerolaMBoerwinkleESingCF. Apolipoprotein E variation at the sequence haplotype level: Implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet2000;67:881–900.
84.
OrdovasJMCorellaD. Nutritional genomics. Annu Rev Genomics Hum Genet2004;5:71–118.
85.
OrdovasJM. The quest for cardiovascular health in the genomic era: Nutrigenetics and plasma lipoproteins. Proc Nutr Soc2004;63:145–52.
86.
EdmondsDKLindsayKSMillerJFWilliamsonEWoodPJ. Early embryonic mortality in women. Fertil Steril1982;38:447–53.
87.
EdwardsRG. Recent scientific and medical advances in assisted human conception. Int J Dev Biol1997;41:255–62.
88.
NelenWLBlomHJSteegersEAden HeijerMEskesTK. Hyperhomocysteinemia and recurrent early pregnancy loss: A meta-analysis. Fertil Steril2000;74:1196–9.
89.
NelenWLBlomHJSteegersEAden HeijerMThomasCMEskesTK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol2000;95:519–24.
90.
NelenWLBlomHJThomasCMSteegersEABoersGHEskesTK. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr1998;128:1336–41.
91.
ShelnuttKPKauwellGPGregoryJF3rdManevalDRQuinlivanEPTheriaqueDWHendersonGNBaileyLB. Methylenetetrahydrofolate reductase 677C→T polymorphism affects DNA methylation in response to controlled folate intake in young women. J Nutr Biochem2004;15:554–60.
92.
HuntJRZengH. Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis. Am J Clin Nutr2004;80:924–31.
93.
SwansonCA. Iron intake and regulation: Implications for iron deficiency and iron overload. Alcohol2003;30:99–102.
94.
MoirandRGuyaderDMendlerMHJouanolleAMLe GallJYDavidVBrissotPDeugnierY. HFE based re-evaluation of heterozygous hemochromatosis. Am J Med Genet2002;111:356–61.
95.
BaierLJHansonRL. Genetic studies of the etiology of type 2 diabetes in Pima Indians: Hunting for pieces to a complicated puzzle. Diabetes2004;53:1181–6.
96.
TseungCWMcMahonLGVazquezJPohlJGregoryJF3rd. Partial amino acid sequence and mRNA analysis of cytosolic pyridoxine-beta-D-glucoside hydrolase from porcine intestinal mucosa: Proposed derivation from the lactase-phlorizin hydrolase gene. Biochem J2004;380(pt 1):211–8.
97.
MackeyADMcMahonRJTownsendJHGregoryJF3rd. Uptake, hydrolysis, and metabolism of pyridoxine-5′-beta-D-glucoside in Caco-2 cells. J Nutr2004;134:842–6.
98.
SeifriedHEAndersonDESorkinBCCostelloRB. Free radicals: The pros and cons of antioxidants. Executive summary report. J Nutr2004;134:3143S–63S.
FinnellRHSpiegelsteinOWlodarczykBTriplettAPogribnyIPMelnykSJamesJS. DNA methylation in Folbp1 knockout mice supplemented with folic acid during gestation. J Nutr2002;132(8 suppl):2457S–61S.
104.
SecklJRMeaneyMJ. Glucocorticoid programming. Ann NY Acad Sci2004;1032:63–84.
105.
SecklJRWalkerBR. Minireview: 11beta-hydroxysteroid dehydrogenase type 1—a tissue-specific amplifier of glucocorticoid action. Endocrinology2001;142:1371–6.
106.
McMillenICRobinsonJS. Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming. Physiol Rev2005;85:571–633.
107.
SecklJR. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol2004;151(suppl 3):U49–62.
108.
WhitePCMuneTAgarwalAK. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev1997;18:135–56.
109.
BertramCTrowernARCopinNJacksonAAWhorwoodCB. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: Potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology2001;142:2841–53.
110.
DrakeAJWalkerBRSecklJR. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am J Physiol Regul Integr Comp Physiol2005;288:R34–8.
111.
GatfordKLWintourEMDe BlasioMJOwensJADodicM. Differential timing for programming of glucose homoeostasis, sensitivity to insulin and blood pressure by in utero exposure to dexamethasone in sheep. Clin Sci (Lond)2000;98:553–60.
RosellaGZajacJDKaczmarczykSJAndrikopoulosSProiettoJ. Impaired suppression of gluconeogenesis induced by overexpression of a noninsulin-responsive phosphoenolpyruvate carboxykinase gene. Mol Endocrinol1993;7:1456–62.
114.
AsipuAHaywardBEO'ReillyJBonthronDT. Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria. Diabetes2003;52:2426–32.
115.
CoxTM. The genetic consequences of our sweet tooth. Nat Rev Genet2002;3:481–7.
116.
AvivAHollenbergNKWederAB. Sodium glomerulopathy: Tubuloglomerular feedback and renal injury in African Americans. Kidney Int2004;65:361–8.
117.
MessierWStewartCB. Episodic adaptive evolution of primate lysozymes. Nature1997;385:151–4.
118.
ZhangJZhangYPRosenbergHF. Adaptive evolution of a duplicated pancreatic ribonuclease gene in a leaf-eating monkey. Nat Genet2002;30:411–5.
119.
WuWGoodmanMLomaxMIGrossmanLI. Molecular evolution of cytochrome C oxidase subunit IV: Evidence for positive selection in simian primates. J Mol Evol1997;44:477–91.
120.
WoodingSPWatkinsWSBamshadMJDunnDMWeissRBJordeLB. DNA sequence variation in a 3.7-kb noncoding sequence 5′ of the CYP1A2 gene: Implications for human population history and natural selection. Am J Hum Genet2002;71:528–42.
121.
JacquesPFBostomAGWilliamsRREllisonRCEckfeldtJHRosenbergIHSelhubJRozenR. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation1996;93:7–9.
122.
TsaiMYYangFBignellMArasOHansonNQ. Relation between plasma homocysteine concentration, the 844ins68 variant of the cystathionine beta-synthase gene, and pyridoxal-5′-phosphate concentration. Mol Genet Metab1999;67:352–6.
123.
AfmanLATrijbelsFJBlomHJ. The H475Y polymorphism in the glutamate carboxypeptidase II gene increases plasma folate without affecting the risk for neural tube defects in humans. J Nutr2003;133:75–7.
124.
DevlinAMLingEHPeersonJMFernandoSClarkeRSmithADHalstedCH. Glutamate carboxypeptidase II: A polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum Mol Genet2000;9:2837–44.
125.
UitterlindenAGFangYBerginkAPvan MeursJBvan LeeuwenHPPolsHA. The role of vitamin D receptor gene polymorphisms in bone biology. Mol Cell Endocrinol2002;197:15–21.
126.
GriffithsWCoxT. Haemochromatosis: Novel gene discovery and the molecular pathophysiology of iron metabolism. Hum Mol Genet2000;9:2377–82.
127.
ZhaoRRussellRGWangYLiuLGaoFKneitzBEdelmannWGoldmanID. Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J Biol Chem2001;276:10224–8.
128.
GellerDS. A genetic predisposition to hypertension?Hypertension2004;44:27–8.
129.
JeckNWaldeggerSLampertABoehmerCWaldeggerPLangPAWissingerBFriedrichBRislerTMoehleRLangUEZillPBondyBSchaeffelerEAsante-PokuSSeyberthHSchwabMLangF. Activating mutation of the renal epithelial chloride channel ClC-Kb predisposing to hypertension. Hypertension2004;43:1175–81.
130.
BentzenJJorgensenTFengerM. The effect of six polymorphisms in the apolipoprotein B gene on parameters of lipid metabolism in a Danish population. Clin Genet2002;61:126–34.
131.
HubacekJAPistulkovaHSkodovaZBergKPoledneR. Association between apolipoprotein B promotor haplotypes and cholesterol status. Ann Clin Biochem2001;38(pt 4):399–400.
132.
BrownSOrdovasJMCamposH. Interaction between the APOC3 gene promoter polymorphisms, saturated fat intake and plasma lipoproteins. Atherosclerosis2003;170:307–13.
133.
HeinDW. Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis. Mutat Res2002;506–507:65–77.
134.
HeinDWDollMAFretlandAJLeffMAWebbSJXiaoGHDevanaboyinaUSNangjuNAFengY. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev2000;9:29–42.
135.
FerreNCampsJFernandez-BallartJArijaVMurphyMMCerueloSBiarnesEVilellaETousMJovenJ. Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clin Chem2003;49:1491–7.
136.
ChistyakovDASavost'anovKVZotovaEVNosikovVV. Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med Genet2001;2:4.
137.
Van LandeghemGFTabatabaiePKucinskasVSahaNBeckmanG. Ethnic variation in the mitochondrial targeting sequence polymorphism of MnSOD. Hum Hered1999;49:190–3.
